A comparison of R-CHOP and R-DA-EPOCH as a first-line regimen treatment of diffuse large B cell lymphoma with non-GCB subtypes: a retrospective study

Saved in:
Bibliographic Details
Published in:Zhōnghuá xuèyèxué zázhì 2022-04, Vol.43 (4), p.346
Main Authors: He, Z Y, Yu, W J, Suo, S S, Wang, J H, Meng, H T, Mai, W Y, Wei, J Y, Yang, M, Mao, L P, Jin, J
Format: Article
Language:Chinese
Subjects:
Antineoplastic Combined Chemotherapy Protocols - therapeutic use
Cyclophosphamide - therapeutic use
Doxorubicin - therapeutic use
Etoposide
Humans
Lymphoma, Large B-Cell, Diffuse - drug therapy
Lymphoma, Large B-Cell, Diffuse - pathology
Prednisone - therapeutic use
Prognosis
Retrospective Studies
Rituximab - therapeutic use
Vincristine - therapeutic use
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0253-2727
DOI:10.3760/cma.j.issn.0253-2727.2022.04.014